Home >> Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 16, Number 1
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics logo Cognizant Communication Corporation logo

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Publisher: Cognizant Communication Corporation

Related content
Volume 16, Number 1, 2006
Purchase this issue

< previous issue | all issues | next issue >

Research article

Inhibition of DMXAA-Induced Tumor Necrosis Factor Production in Murine Splenocyte Cultures by NF-κB Inhibitors
pp. 1-14(14)
Authors: Wang, Liang-Chuan S.; Woon, See-Tarn; Baguley, Bruce C.; Ching, Lai-Ming

ZD6474, an Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase, Inhibits Growth of Experimental Lung Metastasis and Production of Malignant Pleural Effusions in a Non-Small Cell Lung Cancer Model
pp. 15-26(12)
Authors: Matsumori, Yuka; Yano, Seiji; Goto, Hisatsugu; Nakataki, Emiko; Wedge, Stephen R.; Ryan, Anderson J.; Sone, Saburo

FGF-1 as a Possible Carrier for Targeted Drug Delivery
pp. 27-34(8)
Authors: Marcinkowska, Ewa; Superat, Katarzyna; Wieogondłocha, Antoni

The Role of Cell-Free DNA Size Distribution in the Management of Prostate Cancer
pp. 35-41(7)
Authors: Boddy, Jane L.; Gal, Shira; Malone, Peter R.; Shaida, Nadeem; Wainscoat, James S.; Harris, and Adrian L.

Are CYP17 Genotypes a Biomarker for Ovarian Cancer in Patients With Cancer History in Their Family?
pp. 43-47(5)
Authors: Yazici, Hulya; Tigli, Hulya; Kadehci, Zuleyha; Kucucuk, Seden; Saip, Pinar; Issever, Halim; Ozcelik, Hilmi; Dalay, Nejat

Serum Levels of IGF-I and IGFBP-3 in Patients With Lung Cancer During Chemotherapy
pp. 49-54(6)
Authors: Izycki, Tomasz; Chyczewska, Elzbieta; Naumnik, Wojciech; Ossolinska, Maria

< previous issue | all issues | next issue >

The complete issue is available for purchase

$125.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page